First Time Loading...

Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 275.94 USD 0.12% Market Closed
Updated: Apr 28, 2024
Section:
 

Relative Value

The Relative Value of one BIO stock under the Base Case scenario is 454.71 USD. Compared to the current market price of 275.94 USD, Bio Rad Laboratories Inc is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIO Relative Value
Base Case
454.71 USD
Undervaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.9
P/S
P/S
Price to Sales
2.9
vs History
98
vs Industry
57
Median 3Y
5.1
Median 5Y
5.1
Industry
3.9
Forward
2.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
47
Median 3Y
-7.6
Median 5Y
4.3
Industry
30.3
Forward
25.3
More Details
21
P/OCF
P/OCF
Price to OCF
21
vs History
98
vs Industry
29
Median 3Y
29.7
Median 5Y
29.7
Industry
23.2
More Details
31.1
P/FCFE
P/FCFE
Price to FCFE
31.1
vs History
71
vs Industry
21
Median 3Y
37.4
Median 5Y
38.9
Industry
26.9
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
98
vs Industry
76
Median 3Y
1.5
Median 5Y
1.7
Industry
2.5
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
96
vs Industry
55
Median 3Y
4.9
Median 5Y
4.8
Industry
3.8
Forward
2.7
More Details
5.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.2
vs History
96
vs Industry
58
Median 3Y
8.7
Median 5Y
8.5
Industry
7.7
More Details
20.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.4
vs History
96
vs Industry
25
Median 3Y
28
Median 5Y
32.9
Industry
16.8
Forward
15
More Details
20.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.4
vs History
96
vs Industry
31
Median 3Y
28
Median 5Y
32.9
Industry
22
Forward
20.5
More Details
19.9
EV/OCF
EV/OCF
Enterprise Value to OCF
19.9
vs History
96
vs Industry
32
Median 3Y
28
Median 5Y
28.2
Industry
21.1
More Details
34.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
34.2
vs History
69
vs Industry
20
Median 3Y
39.7
Median 5Y
39.2
Industry
27.6
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
98
vs Industry
76
Median 3Y
1.2
Median 5Y
1.3
Industry
2.4
More Details

Multiples Across Competitors

BIO Competitors Multiples
Bio Rad Laboratories Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bio Rad Laboratories Inc
NYSE:BIO
7.9B USD 2.9 -12.3 20.4 20.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.8B USD 5.2 37 22.8 33.5
US
Danaher Corp
NYSE:DHR
182.6B USD 4.2 22.6 16.5 20.3
US
IQVIA Holdings Inc
NYSE:IQV
42.6B USD 2.8 31.4 17 26.2
CH
Lonza Group AG
SIX:LONN
38.1B CHF 5.7 58.2 20 29.3
US
Agilent Technologies Inc
NYSE:A
40.4B USD 6 32.7 26.1 31.4
KR
Samsung Biologics Co Ltd
KRX:207940
54.8T KRW 14.8 63.9 33.7 48.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.7B USD 7 33.8 23.6 26.3
US
West Pharmaceutical Services Inc
NYSE:WST
26.5B USD 9 44.6 30.5 36.5
IE
ICON PLC
NASDAQ:ICLR
25.4B USD 3.1 41.5 17.6 27.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
BIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIO stock valuation using valuation multiples.
Wall Street Estimates
BIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.